Initial product to help save lives by improving essential multi-medication administration during sudden cardiac arrest. The Virginia Innovation Partnership Corporation (VIPC) today announced that Virginia Venture Partners (VVP), its equity investment...
September 8th has been identified as a national observance day to bring awareness to Americans of the need for reliable access to critical essential medicines. No American should ever be without the critical essential medicines necessary to sustain life and conquer disease.
Governor Northam Announces AMPAC Fine Chemicals to Expand Petersburg Operation with $25 Million Investment, Adding 156 New Jobs
Pharmaceutical manufacturer is a collaborator in new government-funded partnership to produce essential medications
Source: Bloomberg In Washington, just four miles from the U.S. Capitol, a children’s hospital is forced at times to call up nearby medical centers to see if they can spare the therapies needed for its young cancer patients. In Chicago, a drug called epinephrine, which...
Rosemary Gibson, author of “China Rx: Exposing the Risks of America’s Dependence on China for Medicine,” on why Medicare should require hospitals to buy American-made essential generic medications.
When you pick up your prescription at the pharmacy, it isn’t labelled “made in China,” but odds are that’s where many of your medications come from.
Last month, the U.S.-China Economic and Security Review Commission held a hearing on the United States’ growing reliance on China’s pharmaceutical products. The topic reminded me of a spirited discussion described in Bob Woodward’s book, Fear: Trump in the White House.
China has become the world’s largest supplier of active pharmaceutical ingredients, or API, providing key components to drugmakers worldwide. But a yearlong recall of tainted heart drugs taken by millions of Americans is prompting U.S. national security officials to ask whether China’s growing role in the pharmaceutical supply chain could pose a threat to the health of military personnel.
The world’s most expensive medicine is about to hit the market. A one-time treatment for a devastating infant muscle-wasting disease won approval from the U.S. Food and Drug Administration Friday. Its maker Novartis AG NVS +3.83% says the gene therapy will cost $2.125 million.
The key ingredients for so many essential drugs, from antibiotics and birth control pills to treatments for cancer, depression, high cholesterol and HIV/AIDS, are purchased from China, says Rosemary Gibson, co-author with Janardan Prasad Singh of a new book called “ChinaRx: Exposing the Risks of America’s Dependence on China for Medicine.”